To include your compound in the COVID-19 Resource Center, submit it here.

Analyst picks & changes

Analyst picks & changes

Analyst picks & changes
CompanyBankAnalystCoverageOpinionWk chg4/8 cls
Bind Therapeutics Inc. (NASDAQ:BIND)CowenEric SchmidtDowngradeMarket perform (from outperform)-30%$1.57
Michael KingDowngradeMarket perform (from market outperform)
Schmidt downgraded after Bind reported mixed results from two Phase

Read the full 311 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE